PARP inhibitors (PARPi), known for their ability to induce replication gaps and accelerate replication forks, have become potent agents in anticancer therapy. However, the molecular mechanism underlying PARPi-induced fork acceleration has remained elusive. Here, we show that the first PARPi-induced effect on DNA replication is an increased replication fork rate, followed by a secondary reduction in origin activity. Through the systematic knockdown of human DNA polymerases, we identify POLA1 as mediator of PARPi-induced fork acceleration. This acceleration depends on both DNA polymerase α and primase activities. Additionally, the depletion of POLA1 increases the accumulation of replication gaps induced by PARP inhibition, sensitizing cells to PARPi. BRCA1-depleted cells are especially susceptible to the formation of replication gaps under POLA1 inhibition. Accordingly, BRCA1 deficiency sensitizes cells to POLA1 inhibition. Thus, our findings establish the POLA complex as important player in PARPi-induced fork acceleration and provide evidence that lagging strand synthesis represents a targetable vulnerability in BRCA1-deficient cells.

Institute of Molecular and Translational Medicine Faculty of Medicine and Dentistry Palacky University Olomouc Czech Republic

See more in PubMed

Conti, C. et al. Replication fork velocities at adjacent replication origins are coordinately modified during DNA replication in human cells. Mol. Biol. Cell18, 3059–3067 (2007). 10.1091/mbc.e06-08-0689 PubMed DOI PMC

Loeb, L. A. & Monnat, R. J. Jr. DNA polymerases and human disease. Nat. Rev. Genet.9, 594–604 (2008). 10.1038/nrg2345 PubMed DOI

Lange, S. S., Takata, K. & Wood, R. D. DNA polymerases and cancer. Nat. Rev. Cancer11, 96–110 (2011). 10.1038/nrc2998 PubMed DOI PMC

Burgers, P. M. J. & Kunkel, T. A. Eukaryotic DNA replication fork. Annu. Rev. Biochem.86, 417–438 (2017). 10.1146/annurev-biochem-061516-044709 PubMed DOI PMC

Azarm, K. & Smith, S. Nuclear PARPs and genome integrity. Genes Dev.34, 285–301 (2020). 10.1101/gad.334730.119 PubMed DOI PMC

Ray Chaudhuri, A. & Nussenzweig, A. The multifaceted roles of PARP1 in DNA repair and chromatin remodelling. Nat. Rev. Mol. Cell Biol.18, 610–621 (2017). 10.1038/nrm.2017.53 PubMed DOI PMC

Rose, M., Burgess, J. T., O’Byrne, K., Richard, D. J. & Bolderson, E. PARP inhibitors: clinical relevance, mechanisms of action and tumor resistance. Front. Cell Dev. Biol.8, 564601 (2020). 10.3389/fcell.2020.564601 PubMed DOI PMC

Bryant, H. E. et al. Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase. Nature434, 913–917 (2005). 10.1038/nature03443 PubMed DOI

Farmer, H. et al. Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy. Nature434, 917–921 (2005). 10.1038/nature03445 PubMed DOI

Maya-Mendoza, A. et al. High speed of fork progression induces DNA replication stress and genomic instability. Nature559, 279–284 (2018). 10.1038/s41586-018-0261-5 PubMed DOI

Cong, K. et al. Replication gaps are a key determinant of PARP inhibitor synthetic lethality with BRCA deficiency. Mol. Cell81, 3128–3144 e3127 (2021). 10.1016/j.molcel.2021.06.011 PubMed DOI PMC

Cantor, S. B. Revisiting the BRCA-pathway through the lens of replication gap suppression: “Gaps determine therapy response in BRCA mutant cancer”. DNA Repair107, 103209 (2021). 10.1016/j.dnarep.2021.103209 PubMed DOI PMC

Vaitsiankova, A. et al. PARP inhibition impedes the maturation of nascent DNA strands during DNA replication. Nat. Struct. Mol. Biol. 29, 329–338 (2022). PubMed PMC

Tirman, S., Cybulla, E., Quinet, A., Meroni, A. & Vindigni, A. PRIMPOL ready, set, reprime! Crit. Rev. Biochem. Mol. Biol.56, 17–30 (2021). 10.1080/10409238.2020.1841089 PubMed DOI PMC

Quinet, A. et al. PRIMPOL-mediated adaptive response suppresses replication fork reversal in BRCA-deficient cells. Mol. Cell77, 461–474.e469 (2020). 10.1016/j.molcel.2019.10.008 PubMed DOI PMC

Bai, G. et al. HLTF promotes fork reversal, limiting replication stress resistance and preventing multiple mechanisms of unrestrained DNA synthesis. Mol. Cell78, 1237–1251.e1237 (2020). 10.1016/j.molcel.2020.04.031 PubMed DOI PMC

Gonzalez-Acosta, D. et al. PrimPol-mediated repriming facilitates replication traverse of DNA interstrand crosslinks. EMBO J.40, e106355 (2021). 10.15252/embj.2020106355 PubMed DOI PMC

Piberger, A. L. et al. PrimPol-dependent single-stranded gap formation mediates homologous recombination at bulky DNA adducts. Nat. Commun.11, 5863 (2020). 10.1038/s41467-020-19570-7 PubMed DOI PMC

Rodriguez-Acebes, S., Mouron, S. & Mendez, J. Uncoupling fork speed and origin activity to identify the primary cause of replicative stress phenotypes. J. Biol. Chem.293, 12855–12861 (2018). 10.1074/jbc.RA118.003740 PubMed DOI PMC

Genois, M. M. et al. CARM1 regulates replication fork speed and stress response by stimulating PARP1. Mol. Cell81, 784–800.e8 (2020). PubMed PMC

Giansanti, C. et al. MDM2 binds and ubiquitinates PARP1 to enhance DNA replication fork progression. Cell Rep.39, 110879 (2022). 10.1016/j.celrep.2022.110879 PubMed DOI

Han, T. et al. The antitumor toxin CD437 is a direct inhibitor of DNA polymerase alpha. Nat. Chem. Biol.12, 511–515 (2016). 10.1038/nchembio.2082 PubMed DOI PMC

Ercilla, A. et al. Physiological tolerance to ssDNA enables strand uncoupling during DNA replication. Cell Rep.30, 2416–2429.e2417 (2020). 10.1016/j.celrep.2020.01.067 PubMed DOI

Holzer, S. et al. Structural basis for inhibition of human primase by arabinofuranosyl nucleoside analogues fludarabine and vidarabine. ACS Chem. Biol.14, 1904–1912 (2019). 10.1021/acschembio.9b00367 PubMed DOI PMC

Kang, Z. et al. BRCA2 associates with MCM10 to suppress PRIMPOL-mediated repriming and single-stranded gap formation after DNA damage. Nat. Commun.12, 5966 (2021). 10.1038/s41467-021-26227-6 PubMed DOI PMC

Panzarino, N. J. et al. Replication gaps underlie BRCA-deficiency and therapy response. Cancer Res.81, 1388–1397 (2020). PubMed PMC

Simoneau, A., Xiong, R. & Zou, L. The trans cell cycle effects of PARP inhibitors underlie their selectivity toward BRCA1/2-deficient cells. Genes Dev.35, 1271–1289 (2021). 10.1101/gad.348479.121 PubMed DOI PMC

Taglialatela, A. et al. REV1-Polzeta maintains the viability of homologous recombination-deficient cancer cells through mutagenic repair of PRIMPOL-dependent ssDNA gaps. Mol. Cell81, 4008–4025.e7 (2021). PubMed PMC

Tirman, S. et al. Temporally distinct post-replicative repair mechanisms fill PRIMPOL-dependent ssDNA gaps in human cells. Mol. Cell81, 4026–4040.e4028 (2021). 10.1016/j.molcel.2021.09.013 PubMed DOI PMC

Paes Dias, M. et al. Loss of nuclear DNA ligase III reverts PARP inhibitor resistance in BRCA1/53BP1 double-deficient cells by exposing ssDNA gaps. Mol. Cell81, 4692–4708.e4699 (2021). 10.1016/j.molcel.2021.09.005 PubMed DOI PMC

Kunkel, T. A., Hamatake, R. K., Motto-Fox, J., Fitzgerald, M. P. & Sugino, A. Fidelity of DNA polymerase I and the DNA polymerase I-DNA primase complex from Saccharomyces cerevisiae. Mol. Cell Biol.9, 4447–4458 (1989). PubMed PMC

Zimmermann, M. et al. CRISPR screens identify genomic ribonucleotides as a source of PARP-trapping lesions. Nature559, 285–289 (2018). 10.1038/s41586-018-0291-z PubMed DOI PMC

Nayak, S. et al. Inhibition of the translesion synthesis polymerase REV1 exploits replication gaps as a cancer vulnerability. Sci. Adv.6, eaaz7808 (2020). 10.1126/sciadv.aaz7808 PubMed DOI PMC

Thakar, T. et al. Lagging strand gap suppression connects BRCA-mediated fork protection to nucleosome assembly through PCNA-dependent CAF-1 recycling. Nat. Commun.13, 5323 (2022). 10.1038/s41467-022-33028-y PubMed DOI PMC

Valli, C. et al. Atypical retinoids ST1926 and CD437 are S-phase-specific agents causing DNA double-strand breaks: significance for the cytotoxic and antiproliferative activity. Mol. Cancer Ther.7, 2941–2954 (2008). 10.1158/1535-7163.MCT-08-0419 PubMed DOI

Johnson, N. et al. Stabilization of mutant BRCA1 protein confers PARP inhibitor and platinum resistance. Proc. Natl Acad. Sci. USA110, 17041–17046 (2013). 10.1073/pnas.1305170110 PubMed DOI PMC

Takata, K. et al. Conserved overlapping gene arrangement, restricted expression, and biochemical activities of DNA polymerase nu (POLN). J. Biol. Chem.290, 24278–24293 (2015). 10.1074/jbc.M115.677419 PubMed DOI PMC

Oxidative DNA Damage and Arterial Hypertension in Light of Current ESC Guidelines